Company news: SDI and Cegedim

Share this article:

SDI and Cegedim Strategic Data are partnering on a market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit, a monthly service to launch in January, will “provide nationally projected measures of personal selling in the oncology market, including competitive corporate calls, details, messages, and promotional spending,” and will allow analysis by tumor type, staging, and modalities, the two market research firms said.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.